Allogeneic adoptive immunochemotherapy for treatment of renal cell carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alemtuzumab; Tacrolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 29 Jan 2015 Biomarkers information updated
- 02 Oct 2005 New trial record.